From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
Characteristics | n (%) |
---|---|
Age, years | 49.0 ± 6.5 |
BMIa, kg/m2 | 24.8 ± 4.6 |
Parity | 1.8 ± 0.7 |
Menopause | 40 (16.0) |
Diabetes | 9 (3.6) |
Hypertension | 35 (14.0) |
Tamoxifen | 21 (8.4) |
Abnormal uterine bleeding | 154 (61.6) |
EM sampling method | |
D&C | 100 (40.0) |
Aspiration biopsy | 150 (60.0) |
Time interval between EM sampling & hysterectomy, months | 1.6 ± 1.0 |
EM sampling pathology | |
SH | 76 (30.4) |
CH | 42 (16.8) |
SAH | 4 (1.6) |
CAH | 128 (51.2) |
Hysterectomy pathology | |
Normal | 35 (14.0) |
SH | 68 (27.2) |
CH | 24 (9.6) |
SAH | 3 (1.2) |
CAH | 64 (25.6) |
Carcinoma | 56 (22.4) |